Medication info
Hypogen A Tablet 5/160/20 mg

Hypogen A Tablet 5/160/20 mg

Prescription medicationTabletOral
Ingredient · strength
Amlodipine Besylate›6.94mg / 1 tabletValsartan›160mg / 1 tabletAtorvastatin Calcium Hydrate›21.7mg / 1 tablet
Manufacturer / importer
Genewon Science Co., Ltd.
Appearance
Pale pink oval film-coated tablet
Packaging
30 tablets/bottle, 100 tablets/bottle
Approval status
Active

MFDS item code 202105296 · Approved 2021.07.12

Summary

Main use
Treatment of hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease
Who takes it
Adults
Adult dose
Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. Before administering the amlodipine/valsartan combination, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Ingredients

Manufacturer
Genewon Science Co., Ltd.

Efficacy & effects

Treatment of hypertension, improvement of dyslipidemia, and prevention of cardiovascular disease

  • Essential hypertension
  • primary hypercholesterolemia
  • mixed dyslipidemia
  • primary dysbetalipoproteinemia
  • elevated serum triglycerides
  • homozygous familial hypercholesterolemia
View approved original text

This medication is used for patients who require treatment for hypertension that is not adequately controlled by other antihypertensives, incorporating a combination of amlodipine and valsartan, and for patients who need to take atorvastatin to reduce cardiovascular disease risk and improve dyslipidemia. The amlodipine/valsartan combination is used when blood pressure is not well controlled in essential hypertension, while atorvastatin helps to reduce the risk of cardiovascular diseases such as myocardial infarction, stroke, and angina, and treats hypercholesterolemia and dyslipidemia. The combination of these two medications aids in improving cardiovascular health and effectively managing blood pressure and blood lipid levels.

How to take

Adult dose

Take 1 tablet once daily with water. It is recommended to take this medicine at the same time each day, if possible (e.g., in the morning). This medicine is for adults only. The dose should be individualized for each patient based on the efficacy and tolerability of the amlodipine/valsartan combination and atorvastatin. Patients taking an amlodipine/valsartan combination and atorvastatin as separate medicines may switch to this medicine (a combination tablet containing the same amounts of each active ingredient) for convenience. Before administering the amlodipine/valsartan combination, it is recommended that the dose of each individual component (amlodipine or valsartan) be adjusted. However, if blood pressure is not controlled with monotherapy using the individual components, switching directly to the amlodipine/valsartan combination may be considered as follows. 5/80 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 80 mg monotherapy. 5/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 5 mg or valsartan 160 mg monotherapy. 10/160 mg: For patients whose blood pressure is not adequately controlled with amlodipine 10 mg or valsartan 160 mg monotherapy, or with 5/160 mg. Patients with renal impairment: No dosage adjustment is necessary in patients with mild or moderate renal impairment (creatinine clearance 10mL/min or higher). However, the amlodipine/valsartan combination should not be administered to patients with severe renal impairment (creatinine clearance below 10mL/min) or patients on dialysis. Monitoring of potassium levels and creatinine is recommended in patients with moderate renal impairment. Patients with hepatic impairment: In patients with mild or moderate hepatic impairment, the daily dose of valsartan should not exceed 80mg. Do not administer the amlodipine/valsartan combination to patients with severe hepatic impairment, biliary cirrhosis, biliary obstruction, or cholestasis. Elderly patients aged 65 years or older: Use caution when increasing the dose. Patients receiving atorvastatin, both before and during treatment, should follow a standard cholesterol-lowering diet. The medicine may be taken at any time of day, with or without food. Dyslipidemia The recommended initial dose is 10 mg of atorvastatin once daily. For patients requiring a greater reduction in LDL cholesterol, treatment may be initiated at 20 mg or 40 mg once daily (only when a reduction in LDL cholesterol of 45 % or more is required). This medicine is administered once daily in a dose range of 10 ~ 80 mg. The initial and maintenance doses should be individualized according to the patient's characteristics, taking into account the treatment goal and response. Lipid levels should be analyzed within 2 ~ 4 weeks after starting treatment and/or dose titration, and the dose should be adjusted accordingly. Patients with homozygous familial hypercholesterolemia The dose is 10 ~ 80 mg once daily. Administer this medicine in combination with other lipid-lowering treatments (e.g., LDL apheresis), or when such treatments are not available. Patients with renal impairment: Renal disease does not affect plasma concentrations of atorvastatin or its LDL cholesterol-lowering effect; therefore, no dosage adjustment is necessary. Elderly patients: Efficacy and safety in patients aged 70 years or older are generally similar to those in the general adult patient population.

Precautions

This medication can cause serious harm to the fetus and newborn if taken during the second and third trimesters of pregnancy; therefore, it should be discontinued immediately upon confirmation of pregnancy. Discontinue this medication if experiencing unusual muscle-related symptoms or a significant increase in muscle enzyme levels, particularly in patients with acute infections or severe trauma. Patients allergic to any components of this medication or with certain liver and kidney diseases, or those who are pregnant or breastfeeding, should not take this medication. Patients with conditions such as hypotension, dehydration, or hyperkalemia should carefully assess their status before taking this medication, and monitor blood pressure and potassium levels frequently while on this medication. Patients with heart failure or post-myocardial infarction may experience changes in renal function while taking this medication, thus regular check-ups are necessary. Dose adjustments are required for patients with poor liver function; if symptoms of hepatitis or liver dysfunction occur, discontinue use immediately and consult a physician. Caution is necessary as dizziness or fatigue may arise when driving or operating machinery. Drug interactions may occur when taken with other medications; therefore, inform your doctor or pharmacist of any other medications being taken. During use of this medication, if symptoms such as muscle pain, weakness, or fever occur, inform a doctor immediately and check for possible muscle damage through blood tests if necessary. Breastfeeding women should avoid taking this medication, and women planning to become pregnant should utilize appropriate contraceptive methods.

Side effects

  • Dry eyes
  • nausea
  • headache
  • nasopharyngitis
  • influenza
  • hypersensitivity
  • visual impairment
  • anxiety
  • dizziness
  • drowsiness
Show 152 more
  • positional dizziness
  • paresthesia
  • vertigo
  • tinnitus
  • tachycardia
  • palpitations
  • syncope
  • orthostatic hypotension
  • hypotension
  • cough
  • pharyngeal and laryngeal pain
  • diarrhea
  • abdominal pain
  • constipation
  • dry mouth
  • rash
  • erythema
  • hyperhidrosis
  • pruritus
  • joint swelling
  • low back pain
  • arthritis
  • muscle spasm
  • lethargy
  • polyuria
  • polydipsia
  • erectile dysfunction
  • edema
  • localized edema
  • facial edema
  • peripheral edema
  • fatigue
  • flushing
  • weakness
  • facial flushing
  • diplopia
  • thrombocytopenia
  • leukopenia
  • allergic reaction
  • hyperglycemia
  • insomnia
  • emotional changes
  • tremor
  • taste alteration
  • peripheral neuropathy
  • hypertonia
  • arrhythmia
  • bradycardia
  • atrial fibrillation
  • ventricular tachycardia
  • myocardial infarction
  • vasculitis
  • angioedema
  • urticaria
  • erythema multiforme
  • dyspnea
  • rhinitis
  • vomiting
  • dyspepsia
  • pancreatitis
  • hepatitis
  • jaundice
  • alopecia
  • purpura
  • skin depigmentation
  • photosensitivity reaction
  • angioedema
  • urticaria
  • Stevens-Johnson syndrome
  • myalgia
  • dysuria
  • enuresis
  • gynecomastia
  • pain
  • malaise
  • chest pain
  • weight loss
  • weight gain
  • decreased hemoglobin
  • decreased hematocrit
  • neutropenia
  • serum sickness
  • hyperkalemia
  • renal failure
  • kidney injury
  • elevated serum creatinine
  • weakness
  • chest pain
  • peripheral edema
  • fatigue
  • fever
  • rhinitis
  • hyperglycemia
  • hypoglycemia
  • weight gain
  • anorexia
  • constipation
  • abdominal distention
  • dyspepsia
  • diarrhea
  • abdominal pain
  • vomiting
  • belching
  • pharyngeal laryngeal pain
  • epistaxis
  • insomnia
  • nightmares
  • perceptual disturbances
  • amnesia
  • peripheral neuropathy
  • urticaria
  • skin rash
  • alopecia
  • angioneurotic edema
  • erythema multiforme
  • gynecomastia
  • abnormal liver function tests
  • elevated serum CK
  • positive urinary leukocytes
  • nightmares
  • blurred vision
  • tinnitus
  • hearing loss
  • thrombocytopenia
  • leukopenia
  • anemia
  • decreased testosterone
  • increased cholinesterase
  • elevated TSH
  • elevated ACTH
  • decreased aldosterone
  • gynecomastia
  • increased potassium
  • elevated BUN
  • cerebral ischemia
  • palpitations
  • tachycardia
  • chest discomfort
  • abdominal discomfort
  • gastroesophageal reflux disease
  • neck pain
  • hypercholesterolemia
  • hypoglycemia
  • enuresis
  • arthralgia
  • myalgia
  • rhabdomyolysis
  • gingival hyperplasia
  • gastritis
  • neuroirritability
  • sensory loss
  • Stevens-Johnson syndrome

Not everyone experiences these, and they can vary from person to person.

Storage

Store this medication in a tightly closed container to prevent exposure to air or moisture. Additionally, keep it at room temperature, neither too hot nor too cold, ideally between 1°C and 30°C.

Appearance and packaging

Appearance

Pale pink oval film-coated tablet

Package unit

30 tablets/bottle, 100 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.